Doximity Analyst Price Targets - Benzinga

Doximity Inc

DOCSNYSE

Trade with Public

Trade with Public

$29.26

8.6041.63%

Last update: Aug 7, 2:03 PM

PRO

Why Is It Moving?™:Doximity shares are trading higher after the company reported better-than-e...

Earnings: Q1 2027 Earnings were released on Thu Aug 6th, after the market close

Conference Call: The most recent conference call started at 5:00 PM, 1 day ago

Click to view the webcast

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Doximity Analyst Price Targets

Wall Street analyst price targets and consensus rating for Doximity (DOCS).

Price Target Range — 8 Quarters

Analyst Consensus — 18 Analysts

1S.Buy

7Buy

9Hold

1Sell

Consensus RatingNeutral# Analysts18Avg. Consensus PT$35Upside to Avg. PT+20.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 7, 2026	JP Morgan	Alexei Gogolev	PT Raise	Neutral	$26→$31
Aug 7, 2026	Piper Sandler	Jessica Tassan	PT Raise	Overweight	$42→$47
Aug 7, 2026	Evercore ISI Group	Elizabeth Anderson	PT Raise	In-Line	$22→$40
Jun 29, 2026	B of A Securities	Allen Lutz	Downgrade	Buy→Underperform	$38→$20
May 15, 2026	Goldman Sachs	David Roman	PT Cut	Neutral	$28→$24
May 15, 2026	Barclays	Glen Santangelo	Downgrade	Overweight→Equal-Weight	$38→$20
May 14, 2026	Leerink Partners	Michael Cherny	PT Cut	Outperform	$31→$25
May 14, 2026	Jefferies	Brian Tanquilut	Downgrade	Buy→Hold	$51→$19
May 14, 2026	Canaccord Genuity	Richard Close	PT Cut	Buy	$34→$30
May 14, 2026	JP Morgan	Alexei Gogolev	PT Cut	Neutral	$33→$28
May 14, 2026	Goldman Sachs	David Roman	PT Cut	Neutral	$28→$24
May 14, 2026	Truist Securities	Jailendra Singh	PT Cut	Hold	$29→$19
May 14, 2026	Wells Fargo	Stan Berenshteyn	Downgrade	Overweight→Equal-Weight	$32→$18
May 14, 2026	BMO Capital	Sean Dodge	PT Cut	Market Perform	$25→$20
May 14, 2026	Mizuho	Steven Valiquette	PT Cut	Neutral	$34→$26
May 14, 2026	Morgan Stanley	Ricky Goldwasser	PT Cut	Overweight	$49→$35
May 14, 2026	BTIG	David Larsen	Downgrade	Buy→Neutral	—
May 14, 2026	Keybanc	Scott Schoenhaus	Downgrade	Overweight→Sector Weight	—
May 14, 2026	Needham	Ryan MacDonald	PT Cut	Buy	$55→$27
May 14, 2026	Baird	Vikram Kesavabhotla	Downgrade	Outperform→Neutral	$40→$18

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on Doximity, Raises Price Target to $31

JP Morgan analyst Alexei Gogolev maintains Doximity (NYSE:DOCS) with a Neutral and raises the price target from $26 to $31.

Benzinga Newsdesk

PRO
Piper Sandler Reiterates Overweight on Doximity, Raises Price Target to $47

Piper Sandler analyst Jessica Tassan reiterates Doximity (NYSE:DOCS) with a Overweight and raises the price target from $42 to $47.

Benzinga Newsdesk

Doximity's AI Expansion Raises Execution Risks: Analyst

BofA downgrades Doximity (DOCS) to Underperform, slashing the price target to $20 amid soft pharma ad demand and AI execution risks.

Vandana Singh

This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed outlook on top stocks. See all changes including upgrades, downgrades, and initiations on analyst ratings page.

Avi Kapoor

PRO
B of A Securities Downgrades Doximity to Underperform, Lowers Price Target to $20

B of A Securities analyst Allen Lutz downgrades Doximity (NYSE:DOCS) from Buy to Underperform and lowers the price target from $38 to $20.

Benzinga Newsdesk

PRO
Goldman Sachs Maintains Neutral on Doximity, Lowers Price Target to $24

Goldman Sachs analyst David Roman maintains Doximity (NYSE:DOCS) with a Neutral and lowers the price target from $28 to $24.

Benzinga Newsdesk